17-3724127-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_031965.2(HASPIN):c.192C>A(p.Asp64Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000552 in 1,594,410 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_031965.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HASPIN | NM_031965.2 | c.192C>A | p.Asp64Glu | missense_variant | 1/1 | ENST00000325418.5 | NP_114171.2 | |
ITGAE | NM_002208.5 | c.3085-383G>T | intron_variant | ENST00000263087.9 | NP_002199.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HASPIN | ENST00000325418.5 | c.192C>A | p.Asp64Glu | missense_variant | 1/1 | 6 | NM_031965.2 | ENSP00000325290.4 | ||
ITGAE | ENST00000263087.9 | c.3085-383G>T | intron_variant | 1 | NM_002208.5 | ENSP00000263087.4 | ||||
ITGAE | ENST00000570415.5 | n.479-383G>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000462 AC: 7AN: 151532Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000954 AC: 21AN: 220134Hom.: 0 AF XY: 0.000106 AC XY: 13AN XY: 122338
GnomAD4 exome AF: 0.0000561 AC: 81AN: 1442878Hom.: 0 Cov.: 32 AF XY: 0.0000585 AC XY: 42AN XY: 718056
GnomAD4 genome AF: 0.0000462 AC: 7AN: 151532Hom.: 0 Cov.: 33 AF XY: 0.0000405 AC XY: 3AN XY: 74036
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 11, 2024 | The c.192C>A (p.D64E) alteration is located in exon 1 (coding exon 1) of the GSG2 gene. This alteration results from a C to A substitution at nucleotide position 192, causing the aspartic acid (D) at amino acid position 64 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at